MCE-new for Detection of Gastric Lesions

Launched by CHANGHAI HOSPITAL · Aug 30, 2023

Keywords

ClinConnect Summary

This clinical trial, called "MCE-new for Detection of Gastric Lesions," is studying a new method called magnetically controlled capsule endoscopy. This technique uses a small capsule that patients swallow, which helps doctors see inside the stomach and check for any abnormalities or lesions. The trial aims to gather information on how effective this method is compared to traditional approaches.

To be eligible for this trial, participants must be at least 18 years old and have previously undergone a gastric examination. However, individuals with swallowing difficulties, certain gastrointestinal issues, or who have specific medical devices implanted (like pacemakers) cannot participate. The trial is not yet recruiting participants, but once it starts, selected individuals can expect to take part in a safe and monitored process to help improve gastric health detection.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • underwent gastric examination;
• • At least 18 years old；
• • Be able to provide informed consent.
• Exclusion Criteria:
• • With swallowing obstruction or disorders;
• • With known or suspected gastrointestinal obstruction, stenosis and fistula;
• • Have no conditions for surgery or refuse to undergo any abdominal surgery;
• • Be allergic to or have other known contraindication or intolerance to the drug used in the study;
• • With pacemakers or other electronic devices such as electronic cochlear implants, implanted magnetic metal drug infusion pumps, neurostimulators, and magnetic metal foreign bodies;
• • Women during pregnancy;
• • Currently enrolled in another clinical trial of a drug or device;
• • Other conditions determined by the investigator to be inappropriate for enrollment.